Rising Trend of E-Cigarette Use Among Queensland Youth: Report

Sep.12.2024
Rising Trend of E-Cigarette Use Among Queensland Youth: Report
Queensland Health Department data shows a significant rise in e-cigarette use among Queensland students, prompting government action.

According to a report by Mirage News on September 11th, the latest data from the Queensland Health Department in Australia indicates a significant increase in the proportion of students in Queensland attempting to use e-cigarettes.


According to reports, between 2022 and 2023, 35.6% of students aged 12 to 17 have tried e-cigarettes, more than twice the 15.5% reported in 2017. Additionally, in 2022, 45.3% of young people aged 18 to 29 have used e-cigarettes, compared to only 23.5% in 2018.


In order to combat and prevent the supply of illegal tobacco and e-cigarette products, the Queensland Department of Health is collaborating with the Queensland Police Service and federal agencies such as the Therapeutic Goods Administration (TGA) and Border Force to enforce relevant state and federal regulations. Last year, the Queensland Department of Health also launched the "There's Nothing Sweet About Vapes" campaign on social media platforms to emphasize the harmful chemicals and health impacts.


In addition, the Miles government will increase funding for the quit smoking hotline to $5.1 million Australian dollars per year, ensuring tailored support for nicotine addicts, including young people. The Queensland health and education departments have jointly launched the "Quit Pathways" program, aimed at developing and implementing an e-cigarette and tobacco cessation support plan for high school students (aged 12-18).


The Miles government is moving forward with new regulations that, if passed, will increase penalties for the commercial supply or possession of illegal nicotine products such as e-cigarettes and black market tobacco. Queensland Minister for Health, Mental Health, Ambulance Services and Women Shannon Fentiman stated:


New e-cigarette data has shocked many, prompting the Queensland government to take strong measures to protect its residents from the harmful effects of e-cigarettes and tobacco products. While the decreasing rate of tobacco smoking is a positive development, the extremely concerning use of e-cigarettes among young people in Queensland is alarming. It is clear that e-cigarettes are attracting young people with their attractive packaging and flavors such as blueberry and bubblegum.


Chief Medical Officer Dr. John Gerrard stated:


I am very concerned about the increasing use of e-cigarettes among young Queenslanders, as the evidence of potential health risks continues to grow. Data indicates that the situation is worsening. The various health risks associated with e-cigarettes are expanding, including lung damage, nicotine addiction and toxicity, as well as adverse effects on mental health. Of particular concern for adolescents is the potential for e-cigarettes to lead to tobacco use. Non-smokers who use e-cigarettes are three times more likely to start smoking.


If the new law is passed, it is expected to impose the strictest nationwide penalties on illegal retailers in order to address this significant public health issue.


We welcome news tips, article submissions, interview requests, or comments on this piece.

Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn


Notice

1.  This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.

2.  The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.

3.  This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.

4.  Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.

 

Copyright

 

This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.

For copyright-related inquiries, please contact: info@2firsts.com

 

AI Assistance Disclaimer

 

This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.

We welcome any corrections or feedback. Please contact us at: info@2firsts.com

Special Report | Can Nicotine Be Replaced? 6-MN Is Already on the Market While Key Human Evidence Is Still Missing
Special Report | Can Nicotine Be Replaced? 6-MN Is Already on the Market While Key Human Evidence Is Still Missing
Nicotine analogues such as 6-methylnicotine are already appearing in e-cigarettes and oral pouches, even as key human evidence remains limited. A new Nixodine-S study adds nonclinical data showing differences from nicotine in cytotoxicity and receptor activity, while independent studies point to a more complex toxicological picture. With supply-chain activity growing and FDA seeking clearer authority over nicotine analogues, the industry now faces a larger question: what evidence is needed before these substances can credibly replace nicotine?
SCIENCE
Sep.23
Product | PMJ Adds Bold Ruby to IQOS ILUMA i Lineup in Japan, Convenience-Store Rollout Starts Sept. 29
Product | PMJ Adds Bold Ruby to IQOS ILUMA i Lineup in Japan, Convenience-Store Rollout Starts Sept. 29
Philip Morris Japan (PMJ) launched Bold Ruby as a new regular color for the IQOS ILUMA i and IQOS ILUMA i ONE in Japan on September 16, 2026, priced at JPY 6,980 and JPY 3,980, respectively. Initial sales began through IQOS online and physical channels, with convenience stores and selected tobacco retailers set to follow from September 29. Bold Ruby is a regular rather than limited-edition colorway and is available for the ILUMA i and ILUMA i ONE, but not the ILUMA i PRIME. The release does not involve changes to the devices' core hardware or functions.
Sep.22
Australia Adds 6-Methylnicotine to Schedule 9 Prohibited Substances, Effective October 1
Australia Adds 6-Methylnicotine to Schedule 9 Prohibited Substances, Effective October 1
Australia's Therapeutic Goods Administration published a final decision on September 25 to classify 6-methylnicotine as a Schedule 9 prohibited substance under the Poisons Standard, effective October 1, 2026. TGA said the chemical has been reported in e-cigarette liquids sold in Australia and marketed as nicotine-free or nicotine alternatives, while evidence also indicates its use in preparations such as oral pouches. The government originally proposed a Schedule 7 classification but ultimately adopted the stricter Schedule 9 designation, citing acute toxicity, dependence risk, use in unapproved consumer products and misleading marketing.
News
Sep.29 by 2Firsts Perspectives
2Firsts Compliance Solutions Hosts PMTA Briefing on FDA Review Signals After JUUL2 Authorization
2Firsts Compliance Solutions Hosts PMTA Briefing on FDA Review Signals After JUUL2 Authorization
Following recent FDA authorizations for JUUL2 and ZYN ULTRA, 2Firsts Compliance Solutions held an online PMTA briefing on Sept. 4 to examine what the decisions may signal about review efficiency, scientific evidence and U.S. market access. Nearly 30 participants from brands, manufacturers, compliance service providers and investment firms joined the discussion.
2Firsts Events
Sep.06
UK HMRC Issues One-Month Countdown Warning, Urges Vape Businesses to Prepare for New Tax Rules
UK HMRC Issues One-Month Countdown Warning, Urges Vape Businesses to Prepare for New Tax Rules
The UK’s Vaping Products Duty and Vaping Duty Stamps Scheme will take effect on October 1, 2026. All vaping liquids manufactured in or imported into the UK will face a flat excise duty of £2.20 per 10ml, whether or not they contain nicotine. Newly manufactured or imported products released onto the UK market from October 1 will require a valid duty stamp, while eligible existing unstamped inventory can continue to be sold through March 31, 2027. From April 1, 2027, all vaping products outside duty suspension must carry a valid stamp.
Sep.03
JTI Invests ₱2.1 Billion to Upgrade Batangas Manufacturing Hub, Adds First Southeast Asia DIET Facility
JTI Invests ₱2.1 Billion to Upgrade Batangas Manufacturing Hub, Adds First Southeast Asia DIET Facility
JTI Asia Manufacturing Corp. has invested ₱2.1 billion, or about $37 million, in its manufacturing site in Malvar, Batangas, Philippines, to expand tobacco-processing capabilities. About ₱1.9 billion is allocated to JTI's first Dry Ice Expanded Tobacco, or DIET, facility in Southeast Asia, while more than ₱177 million has been spent on expanding its Controlled Atmosphere treatment facility. The Batangas plant supplies the Philippine market and exports to 22 overseas markets, making it one of JTI's key manufacturing hubs in Asia.
Sep.24